Special Issue "Magnetic Nanoparticles (MNPs) in Biomedical Applications"
Deadline for manuscript submissions: 15 March 2024 | Viewed by 1844
Magnetic nanoparticles are currently reshaping medical nanotechnologies and applications. Publications on biomedical applications of magnetic nanoparticles increased by more than three orders of magnitude over the past two decades, with a corresponding increase in patents, clinical trials, clinical applications, and medical devices. Examples include magnetic resonance imaging, magnetic hyperthermia for cancer, bone, brain, liver, and pancreas therapies, targeted drug delivery, tissue engineering, biosensors, and other biomedical applications. Synthetic and characterization approaches have also increased, providing insights into an increasing range of nano-morphologies including spheres, crystals, rods, stars, flowers, wires, and sheets, and these are increasingly engineered into multi-functional nanoconjugates used in bio-environmental and stimulus-responsive drug delivery and release.
Paramagnetic and superparamagnetic metal, alloy, chalcogenide, and ferrite nanoparticles of iron, nickel, cobalt, gadolinium, and other metals are commonly used. Biocompatibility is achieved through polymeric, biomimetic membrane encapsulation, cloaking, and functionalization with target cell membrane and internal component molecules such as aptamers and folate for cancer cell targeting. These developments have led to novel innovations promising reduction of disease burden. The special issue will publish research and review articles on the foregoing and other relevant reflections, perspectives, and research investigations.
The range of articles includes disease detection and diagnosis, therapeutic applications, image-guided theragnostic, combination therapies, design and fabrication of nanoconjugates for biomedical applications, in-vitro, in-vivo, and clinical applications, and biomedical devices. Environmental applications aimed at reducing the burden of disease are considered to be an important part of biomedical disease prevention.
Prof. Dr. Sandile Phinda Songca
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- magnetic nanoparticles
- magnetic resonance imaging
- magnetic hyperthermia
- cancer therapy
- bone therapy
- magnetically targeted drug delivery
- magnetic hyperthermia drug release
- tissue engineering